American Gene Technologies International Stock
American Gene Technologies develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders.
Sign up today and learn more about American Gene Technologies International Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About American Gene Technologies International Stock
American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. It develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders. The company's mission is to leverage the power of gene and cell therapy to reduce human suffering from serious human diseases. American Gene Technologies was established in 2007 and is headquartered in Rockville, Maryland.
Funding History
| September 2013 | $1.3M |
|---|---|
| October 2014 | $340K |
Management
CEO & Founder
Jeffrey A. Galvin
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
